- Home
- APRE vs SPPL Comparison
APRE vs SPPL Comparison
Compare APRE & SPPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APRE
- SPPL
- Stock Information
- Founded
- APRE 2006
- SPPL 2016
- Country
- APRE United States
- SPPL Singapore
- Employees
- APRE N/A
- SPPL N/A
- Industry
- APRE Biotechnology: Biological Products (No Diagnostic Substances)
- SPPL
- Sector
- APRE Health Care
- SPPL
- Exchange
- APRE Nasdaq
- SPPL Nasdaq
- Market Cap
- APRE 15.8M
- SPPL 14.8M
- IPO Year
- APRE 2019
- SPPL 2023
- Fundamental
- Price
- APRE $3.05
- SPPL $0.80
- Analyst Decision
- APRE Strong Buy
- SPPL
- Analyst Count
- APRE 2
- SPPL 0
- Target Price
- APRE $15.50
- SPPL N/A
- AVG Volume (30 Days)
- APRE 22.6K
- SPPL 217.8K
- Earning Date
- APRE 11-07-2024
- SPPL 12-31-2024
- Dividend Yield
- APRE N/A
- SPPL N/A
- EPS Growth
- APRE N/A
- SPPL N/A
- EPS
- APRE N/A
- SPPL N/A
- Revenue
- APRE $1,310,839.00
- SPPL $3,550,862.00
- Revenue This Year
- APRE $134.21
- SPPL N/A
- Revenue Next Year
- APRE N/A
- SPPL N/A
- P/E Ratio
- APRE N/A
- SPPL N/A
- Revenue Growth
- APRE 130.31
- SPPL N/A
- 52 Week Low
- APRE $2.15
- SPPL $0.25
- 52 Week High
- APRE $8.85
- SPPL $6.72
- Technical
- Relative Strength Index (RSI)
- APRE 43.20
- SPPL 42.72
- Support Level
- APRE $3.02
- SPPL $0.81
- Resistance Level
- APRE $3.39
- SPPL $0.94
- Average True Range (ATR)
- APRE 0.30
- SPPL 0.07
- MACD
- APRE -0.01
- SPPL -0.04
- Stochastic Oscillator
- APRE 3.85
- SPPL 12.15
About APRE Aprea Therapeutics Inc. Common stock
Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company. The group is focused on precision oncology through synthetic lethality. Its pipeline product is ATRN-119, a clinical-stage small molecule ATR inhibitor in development for solid tumor indications. APR-1051, an oral, small-molecule WEE1 inhibitor, recently entered the clinic.
About SPPL SIMPPLE LTD.
Simpple Ltd delivers an ecosystem solution that combines Internet-of-Things devices, robotic solutions and an integrated software system operating in unison to position buildings to be future-ready. The company operates through two primary segments: the sale, warranty, and maintenance of autonomous robotic cleaning equipment (Robots), and the sale of facilities management software. The majority of its revenue is generated from the Robots segment.